Search Share Prices
AZN Headlines - AstraZeneca share price: Group wraps up Nexium and Vimovo rights sale
AstraZeneca (LON:AZN) has wrapped up the divestment of some rights to Nexium and Vimovo, the blue-chip pharmco has said. The deal, announced in October, is part of the Anglo-Swedish drugmaker’s ...
Redx Pharma looks for some Porcupine help in its fight against cancer and fibrosis
Anson was the president of AstraZeneca PLC’s (LON:AZN) UK division immediately prior to joining Redx, while she also held various other senior leadership roles during her 20-year career at the FTSE 10...
AstraZeneca PLC (LON:AZN): The Best Of Both Worlds
Attractive stocks have exceptional fundamentals. In the case of AstraZeneca PLC (LON:AZN), there’s is a company with a an impressive history of dividend payments as well as a excellent future ...
Biocartis Group NV: Biocartis and AstraZeneca Enter Into Agreement Aimed at Faster Lung Cancer Biomarker Results
a global science-led biopharmaceutical company (LON: AZN), aimed at obtaining faster lung cancer molecular diagnostic biomarker results in Europe. Pursuant to the agreement, a prospective lung ...
AstraZeneca share price: US regulator grants orphan drug designation to Fasenra
US regulators have granted an orphan drug designation to AstraZeneca’s (LON:AZN) Fasenra for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA), the blue-chip group has reported.